MarketLens
Sign Up

What Just Happened with Generate Biomedicines' IPO

6 months ago
SHARE THIS ON:

What Just Happened with Generate Biomedicines' IPO

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

The Market Just Told You Which Layer Of AI Biology It Is Paying For

Life sciences tech earnings split cleanly: the data/systems-of-record owner beat and jumped, while the model-informed software seller missed and fell by a similar amount, signaling which AI-biology la...
Stock News2 weeks ago

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

Generate Biomedicines (GENB) shares jumped over 20% Tuesday, ahead of Wednesday's lock-up expiration that frees insiders and early investors to sell shares from its $400 million IPO.
News2 months ago

Sleep apnea pill maker Apnimed files for US IPO as biotech market revives

Apnimed, a late-stage sleep apnea drug developer, filed for a US IPO on Friday, joining a revived biotech IPO market.

Breaking News

View All →

Top Headlines

View More →
Stock News2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News6 hours ago

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today